1. Li K, Luo Y, Hu W, Yang J, Zhang D, Wei H, You T, Lin H-S*, Kuang Z*. Subtle Structural Differences Affect the Inhibitory Potency of RGD-Containing Cyclic Peptide Inhibitors Targeting SPSB Proteins. Int. J. Mol. Sci. 2024; 25, 6764.
2. Zhao P, Zhuang Z, Guan X, Yang J, Wang W, Kuang Z*. Crystal structure of the 3-ketodihydrosphingosine reductase TSC10 from Cryptococcus neoformans. Biochem Biophys Res Commun. 2023; 670:73-8.
3. Li K, You T, Zhao P, Luo Y, Zhang D, Wei H, Wang Y, Yang J, Guan X, Kuang Z*. Structural basis for the regulation of inducible nitric oxide synthase by the SPRY domain-containing SOCS box protein SPSB2, an E3 ubiquitin ligase. Nitric Oxide. 2021; 113-114:1-6.
4. Yang J, Guan X, Zhang D, Zhao P, Guo S, Kuang Z*. Crystal structure of the SPRY domain-containing protein 7 reveals unique structural features. Biochem Biophys Res Commun. 2020; 531(3):350-6.
5. Luo Y, Li K, Yang J, Zhang D, Zhou Y, Kuang Z*. Crystal structure of the SPRY domain of human SPSB2 in the apo state. Acta Crystallogr F Struct Biol Commun. 2019; F75(6): 412-8.
6. Zhang D, Wei H, Xue H, Guo S, Wu B, Kuang Z*. Backbone 1H, 13C, and 15N resonance assignments of the PRY-SPRY domain of RNF135. Biomol NMR Assign. 2019; 13(2): 299-304.
7. You T, Wang Y, Li K, Zhang D, Wei H, Luo Y, Li H, Lu Y, Su X, Kuang Z*. Crystal structure of SPSB2 in complex with a rational designed RGD-containing cyclic peptide inhibitor of SPSB2-iNOS interaction. Biochem Biophys Res Commun. 2017; 489(3):346-52.
8. Hu W, Liu X, Li Y, Liu D, Kuang Z, Qian C, Yao D*. Rational design for the stability improvement of Armillariella tabescens β-mannanase MAN47 based on N-glycosylation modification. Enzyme Microb Technol. 2017; 97:82-9.
9. Kuang Z, Zhang M, Gupta K, Gajewiak J, Gulyas J, Balaram P, Rivier JE, Olivera MO, Yoshikami D, Bulaj G, Norton RS*. Mammalian neuronal sodium channel blocker μ-conotoxin BuIIIB has a structured N-terminus that influences potency. ACS Chem Biol. 2013; 8 (6):1344-51.
10. Lewis RS, Kolesnik TB, Kuang Z, D’Cruz AA, Blewitt ME, Masters SL, Low A, Willson T, Norton RS, Nicholson SE*. Toll-like receptor regulation of SPSB1 controls inducible nitric oxide synthase induction. J Immunol. 2011; 187(7): 3798-805.
11. Safavi-Hemami H, Siero WA, Kuang Z, Williamson NA, Karas JA, Page LR, MacMillan D, Callaghan B, Kompella SN, Adams DJ, Norton RS, Purcell AW*. Embryonic toxin expression in the cone snail Conus victoriae - primed to kill or divergent function? J Biol Chem. 2011; 286(25): 22546-57.
12. Kuang Z, Lewis RS, Curtis JM, Zhan Y, Saunders BM, Babon JJ, Kolesnik YB, Low A, Masters SL, Willson TA, Kedzierski L, Yao S, Handman E, Norton RS*, Nicholson SE*. The SPRY domain-containing SOCS Box protein SPSB2 targets iNOS for proteasomal degradation. J Cell Biol. 2010; 190(1): 129-41.
13. Filippakopoulos P, Low A, Sharpe1 TD, Uppenberg J, Yao S, Kuang Z, Savitsky P, Lewis RS, Nicholson SE, Norton RS*, Bullock AN*. Structural basis for Par-4 recognition by the SPRY domain and SOCS box containing proteins SPSB1, SPSB2 and SPSB4. J Mol Biol. 2010; 401(3): 389-402.
14. Kuang Z, Yao S, Xu Y, Lewis RS, Low A, Masters SL, Willson TA, Kolesnik TB, Nicholson SE, Garrett TJ*, Norton RS*. SPRY domain-containing SOCS box protein 2: crystal structure and residues critical for protein binding. J Mol Biol. 2009; 386(3): 662-74.
15. Kuang Z, Yao S, McNeil KA, Forbes BE, Wallace JC, Norton RS*. Insulin-like growth factor-I (IGF-I): Solution properties and NMR chemical shift assignments near physiological pH. Growth Horm IGF Res. 2009; 19(3): 226-31.
16. Kuang Z, Yao, S, McNeil KA, Thompson JA, Bach LA, Forbes BE, Wallace JC, Norton RS*. Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding. Biochemistry. 2007; 46(48): 13720-32.
17. Kuang Z, Yao S, Keizer DW, Wang CC, Bach LA., Forbes BE, Wallace JC, Norton RS*. Structure, dynamics and heparin binding of the C-terminal domain of insulin-like growth factor-binding protein-2 (IGFBP-2). J Mol Biol. 2006; 364(4): 690-704.